These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. MicroRNA-mediated dysregulation of neural developmental genes in HPRT deficiency: clues for Lesch-Nyhan disease? Guibinga GH; Hrustanovic G; Bouic K; Jinnah HA; Friedmann T Hum Mol Genet; 2012 Feb; 21(3):609-22. PubMed ID: 22042773 [TBL] [Abstract][Full Text] [Related]
3. Guanine nucleotide depletion induces differentiation and aberrant neurite outgrowth in human dopaminergic neuroblastoma lines: a model for basal ganglia dysfunction in Lesch-Nyhan disease. Messina E; Micheli V; Giacomello A Neurosci Lett; 2005 Feb; 375(2):97-100. PubMed ID: 15670649 [TBL] [Abstract][Full Text] [Related]
4. Characterization of the dopamine defect in primary cultures of dopaminergic neurons from hypoxanthine phosphoribosyltransferase knockout mice. Smith DW; Friedmann T Mol Ther; 2000 May; 1(5 Pt 1):486-91. PubMed ID: 10933970 [TBL] [Abstract][Full Text] [Related]
5. Loss of dopamine phenotype among midbrain neurons in Lesch-Nyhan disease. Göttle M; Prudente CN; Fu R; Sutcliffe D; Pang H; Cooper D; Veledar E; Glass JD; Gearing M; Visser JE; Jinnah HA Ann Neurol; 2014 Jul; 76(1):95-107. PubMed ID: 24891139 [TBL] [Abstract][Full Text] [Related]
6. Purinergic signaling in human pluripotent stem cells is regulated by the housekeeping gene encoding hypoxanthine guanine phosphoribosyltransferase. Mastrangelo L; Kim JE; Miyanohara A; Kang TH; Friedmann T Proc Natl Acad Sci U S A; 2012 Feb; 109(9):3377-82. PubMed ID: 22331909 [TBL] [Abstract][Full Text] [Related]
7. Impaired differentiation of HPRT-deficient dopaminergic neurons: a possible mechanism underlying neuronal dysfunction in Lesch-Nyhan syndrome. Yeh J; Zheng S; Howard BD J Neurosci Res; 1998 Jul; 53(1):78-85. PubMed ID: 9670994 [TBL] [Abstract][Full Text] [Related]
8. Deficiency of the housekeeping gene hypoxanthine-guanine phosphoribosyltransferase (HPRT) dysregulates neurogenesis. Guibinga GH; Hsu S; Friedmann T Mol Ther; 2010 Jan; 18(1):54-62. PubMed ID: 19672249 [TBL] [Abstract][Full Text] [Related]
9. HPRT deficiency coordinately dysregulates canonical Wnt and presenilin-1 signaling: a neuro-developmental regulatory role for a housekeeping gene? Kang TH; Guibinga GH; Jinnah HA; Friedmann T PLoS One; 2011 Jan; 6(1):e16572. PubMed ID: 21305049 [TBL] [Abstract][Full Text] [Related]
10. Human neural stem cells: a model system for the study of Lesch-Nyhan disease neurological aspects. Cristini S; Navone S; Canzi L; Acerbi F; Ciusani E; Hladnik U; de Gemmis P; Alessandri G; Colombo A; Parati E; Invernici G Hum Mol Genet; 2010 May; 19(10):1939-50. PubMed ID: 20159777 [TBL] [Abstract][Full Text] [Related]
12. Functional analysis of brain dopamine systems in a genetic mouse model of Lesch-Nyhan syndrome. Jinnah HA; Langlais PJ; Friedmann T J Pharmacol Exp Ther; 1992 Nov; 263(2):596-607. PubMed ID: 1432691 [TBL] [Abstract][Full Text] [Related]
13. Altered membrane NTPase activity in Lesch-Nyhan disease fibroblasts: comparison with HPRT knockout mice and HPRT-deficient cell lines. Pinto CS; Jinnah HA; Shirley TL; Nyhan WL; Seifert R J Neurochem; 2005 Jun; 93(6):1579-86. PubMed ID: 15935074 [TBL] [Abstract][Full Text] [Related]
14. Consequences of impaired purine recycling on the proteome in a cellular model of Lesch-Nyhan disease. Dammer EB; Göttle M; Duong DM; Hanfelt J; Seyfried NT; Jinnah HA Mol Genet Metab; 2015 Apr; 114(4):570-579. PubMed ID: 25769394 [TBL] [Abstract][Full Text] [Related]
15. HPRT-deficiency dysregulates cAMP-PKA signaling and phosphodiesterase 10A expression: mechanistic insight and potential target for Lesch-Nyhan Disease? Guibinga GH; Murray F; Barron N PLoS One; 2013; 8(5):e63333. PubMed ID: 23691025 [TBL] [Abstract][Full Text] [Related]
16. Hypoxanthine-guanine phosphoribosyltransferase (HPRT) deficiency: identification of point mutations in Japanese patients with Lesch-Nyhan syndrome and hereditary gout and their permanent expression in an HPRT-deficient mouse cell line. Tohyama J; Nanba E; Ohno K Hum Genet; 1994 Feb; 93(2):175-81. PubMed ID: 8112742 [TBL] [Abstract][Full Text] [Related]
17. A human neuronal tissue culture model for Lesch-Nyhan disease. Shirley TL; Lewers JC; Egami K; Majumdar A; Kelly M; Ceballos-Picot I; Seidman MM; Jinnah HA J Neurochem; 2007 May; 101(3):841-53. PubMed ID: 17448149 [TBL] [Abstract][Full Text] [Related]
18. Genetic analysis of the HPRT mutation of Lesch-Nyhan syndrome in a Chinese family. Lee WJ; Lee HM; Chi CS; Yang MT; Lin HY; Lin WH Zhonghua Yi Xue Za Zhi (Taipei); 1995 Dec; 56(6):359-66. PubMed ID: 8851475 [TBL] [Abstract][Full Text] [Related]
19. Impairment of adenylyl cyclase 2 function and expression in hypoxanthine phosphoribosyltransferase-deficient rat B103 neuroblastoma cells as model for Lesch-Nyhan disease: BODIPY-forskolin as pharmacological tool. Kinast L; von der Ohe J; Burhenne H; Seifert R Naunyn Schmiedebergs Arch Pharmacol; 2012 Jul; 385(7):671-83. PubMed ID: 22552731 [TBL] [Abstract][Full Text] [Related]
20. Do clinical features of Lesch-Nyhan disease correlate more closely with hypoxanthine or guanine recycling? Schretlen DJ; Callon W; Ward RE; Fu R; Ho T; Gordon B; Harris JC; Jinnah HA J Inherit Metab Dis; 2016 Jan; 39(1):85-91. PubMed ID: 26067813 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]